Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney transplant
Biotech
Cell therapy allows kidney recipients to cut immunosuppressants
Medeor’s kidney transplant cell therapy allowed more than half of study participants in a phase 3 trial to stay off immunosuppressants for two years.
Annalee Armstrong
Nov 2, 2023 10:00am
United Therapeutics buys Miromatrix in $91M xenotransplant deal
Oct 30, 2023 10:45am
CRISPR-edited pig kidney lasts for 2 years in primates
Oct 11, 2023 11:13am
AlloVir's cell therapy tackles virus in kidney transplant trial
Feb 15, 2023 9:45am
Hansa touts phase 2 data of one-trick pony transplant therapy
Nov 28, 2022 3:35pm
Talaris restarts trial after assurance regarding patient death
Oct 20, 2022 10:05am